Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-03-18

Clinical Trial Update: TAU Opioid Use Outcomes Following Discharge From Detoxification and Short Term Residential Programs Affiliated With CTN-0051

View source ↗

Summary

A completed clinical trial evaluating tau opioid use outcomes after discharge from detoxification and short-term residential programs affiliated with CTN-0051.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: NYU Langone Health | Conditions: Opioid Use Disorder | Status: COMPLETED | Results posted: 2020-03-18